Back

3DProtDTA: the deep learning model for drug-target affinity prediction based on the residue-level protein graphs

Voitsitskyi, T.; Stratiichuk, R.; Koleiev, I.; Popryho, L.; Ostrovsky, Z.; Henitsoi, P.; Khropachev, I.; Vozniak, V.; Zhytar, R.; Nechepurenko, D.; Yesylevskyy, S.; Nafiev, A.; Starosyla, S.

2022-11-25 pharmacology and toxicology
10.1101/2022.11.24.517815 bioRxiv
Show abstract

Accurate prediction of the drug-target affinity (DTA) in silico is of critical importance for modern drug discovery. Computational methods of DTA prediction, applied in the early stages of drug development, are able to speed it up and cut its cost significantly. A wide range of approaches based on machine learning was recently proposed for DTA assessment. The most promising of them are based on deep learning techniques and graph neural networks to encode molecular structures. The recent breakthrough in protein structure prediction made by AlphaFold made an unprecedented amount of proteins without experimentally defined structures accessible for computational DTA prediction. In this work, we propose a new deep learning DTA model 3DProtDTA, which utilises AlphaFold structure predictions in conjunction with the graph representation of proteins. The model is superior to its rivals on common benchmarking datasets and has a potential for further improvement.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.